The global Bacillus Coagulans market is expected to reach a market valuation of US$ 164 million by 2023, recording a CAGR of 4.2% from 2023 to 2033.
Bacillus coagulans is a type of bacteria that is utilized as a probiotic due to its ability to withstand harsh acidic environments. This makes it ideal for concentrating on the digestive system in humans, providing relief from various gastrointestinal issues such as stomach aches, constipation, and irritable bowel syndrome. Moreover, this resilient bacterium is also useful in animal feeding as it possesses beneficial properties such as improved immunity, prevention of respiratory ailments, and anti-cancer properties.
| Bacillus Coagulans Market Size (2023E) | US$ 164 million |
| Bacillus Coagulans Market Projected Size (2033F) | US$ 248 million |
| Value CAGR (2023 to 2033) | 4.2% |
| Top 3 Countries Marketing Share | 66.2% |
The global market for Bacillus coagulans has experienced significant growth opportunities due to an increase in demand for functional foods and growing health concerns. The market expansion is further supported by increased research and development expenditures. However, the lack of awareness about the effectiveness of Bacillus coagulans among consumers has hindered its growth. Nonetheless, the market is expected to expand in emerging economies as consumer demand for Bacillus coagulans products increases, creating new opportunities for growth.
In our new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights into key factors driving demand for Bacillus Coagulans.
| Market Statistics | Details |
| Jan–Jun (H1), 2021 (A) | 3.7% |
| Jul–Dec (H2), 2021 (A) | 3.9% |
| Jan–Jun (H1),2022 Projected (P) | 4.0% |
| Jan–Jun (H1),2022 Outlook (O) | 4.1% |
| Jul–Dec (H2), 2022 Projected (P) | 4.5% |
| Jul–Dec (H2), 2022 Outlook (O) | 4.3% |
| Jan–Jun (H1), 2023 Projected (P) | 4.4% |
Bacillus coagulans market is witnessing growing demand in the cosmetic industry, owing to the immense benefits offered in managing acne and skin problems. New formulations including Bacillus coagulans are being launched by cosmetics providers for anti-aging effects. These products include face masks, lotion, scrub, gel, creams, and cleansers. Cosmetics product manufacturers are also focusing on developing cosmeceutical ingredients including bacillus coagulans to be used in various cosmetic products including cream, lotion, powder, and others.
Bacillus coagulans are also gaining popularity in treating and managing symptoms of atopic dermatitis and eczema. Its incorporation in cosmetic products including anti-acne face wash and moisturizing cream is also on a rise. Owing to its biological activity and protection of skin, bacillus coagulans are widely used in personal care products.
Due to the numerous alleged health advantages and nutritional value of this spore-forming bacterium used as probiotics, the opportunities in the worldwide bacillus coagulans market have been growing. On-the-go immune system and digestive health products are a noteworthy trend among consumers in both developing and developed areas.
The potential of the microorganism for a variety of functions connected to shielding people from diseases has increased interest in the use of bacillus coagulants. They support immune system development, guard against tooth decay, and are particularly helpful in preventing coronary heart diseases. Because they are stable in their heat-resistant spore form, this has been a tremendous benefit to food manufacturers.
Functional Foods and Natural Health Products Market:
| Attributes | Functional Foods and Natural Health Products Market |
| CAGR (2023 to 2033) | 5% |
| Market Value (2023) | US$ 23,296 million |
| Growth Factor | The demand for functional foods and natural health products is anticipated to soar throughout the forecast period due to rising health benefits, as well as their capacity to significantly contribute to economic growth, particularly in emerging nations. |
| Key Trend | Even among the health-conscious, the market for snacks is expanding because of innovations like the use of multi-whole grain flour as a base for extruded snacks and chips. |
Dietary Supplements Market:
| Attributes | Dietary Supplements Market |
| CAGR (2023 to 2033) | 9% |
| Market Value (2023) | US$ 68,207 million |
| Growth Factor | The main purpose of dietary supplements is to make up for human nutritional inadequacies. |
| Key Trend | It is projected that this trend will continue in the future, benefiting the global market participants for dietary supplements. The demand for vitamins, minerals, and herbs that promote immunity grew. |
Since North America is the region with the highest consumption, it is excluded from the bacillus coagulans market share. Because of its advanced economy and vast population, North America has a lot of medical and healthcare facilities, which is one of the reasons it took first place. Also, this location has a fantastic network with other parts of the world, which makes the entire transit procedure much simpler and more effective. The market expansion will ultimately profit from North America's ability to obtain the necessary advertising or promotional investment to introduce any new product.
Asia Pacific accounts for a sizable share of the revenue generated by the global bacillus coagulans market, with ASEAN, India, and China thought to be significant markets for bacillus coagulans. Asia Pacific is expected to have a rapidly expanding market due to the region's rising healthcare costs. The growing elderly population in these countries is also a major factor encouraging industry expansion.
A big market for bacillus coagulans in the probiotics sector is projected in Japan because of the nation's extensive usage of traditional medicine. Also, through growing usage of healthcare items, Southeast Asian countries like India are projected to aid the expansion of the bacillus coagulans market.
In 2021, Europe had a sizable market share compared to the other regions. It is because the following substance is used in a variety of applications. For instance, since 21% of the population is above 65, the following chemical is in high demand for treating IBD and other illnesses. About 2.5 to 3 million people in the area suffer from IBD. Second, bacillus coagulans is a crucial component for managing intestinal health and animals. As a result of the significant exports of livestock from the region below, the bacillus coagulans market has dominated and will continue to dominate.
North America is not included in the bacillus coagulans market share because it consumes more than any other area. North America won first place because of its developed economy and sizable population, which contributes to the region's plenty of medical and healthcare facilities. Also, this area has a great network of connections to other regions of the world, which makes the entire transit process much simpler and more efficient. In the end, the market expansion will benefit from North America's capacity to acquire the required advertising or promotional investment to launch any new product.
In 2021, the food and beverage industries controlled a large portion of the market. That is due to the fact that the ingredient listed below is used in numerous beverage applications. For instance, bacillus coagulans is now frequently used in the product launches of cereals. The following component has been added to goods by Kellogg's and other industry titans because it is simple to create and use. Moreover, the pH value's ability to be steady at 4.5 allows it to pass through the digestive system's acids and create a beneficial bacterium.
A USA-based provider of food products, Mariani Packing Company, debuted its probiotics products in June, 2020, in single serve packets with two fruit flavors. The product, which comes in a weekly 7-day supply carton, mixes prebiotics from fruits with bacillus coagulans probiotics. The probiotics GanedenBC30 Bacillus Coagulans GBI-30, 6086 will improve gut and immune health.
Chr. Hansen stated in June 2020, that it had acquired UAS Laboratories LLC in order to broaden its microbial platform and increase the flexibility of its probiotic production. The company's plan to broaden its microbial platform is aligned with the acquisition of UAS Labs, which will strengthen and expand the company's global microbial platform along with its Human Health division.
| Attribute | Details |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ million for Value and Metric Ton for Volume |
| Key Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa |
| Key Countries Covered | United States of America, Canada, Brazil, Mexico, Germany, United Kingdom, France, Italy, Spain, Nordic, Russia, Poland, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Singapore, Australia, New Zealand, GCC countries, North Africa, South Africa, others. |
| Key Segments Covered | Type, End Use, Distribution Channel and Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The Bacillus Coagulans Market is valued at US$ 164 million for 2023.
The Bacillus Coagulans Market valuation is expected to be US$ 248 million in the year 2023.
The value of CAGR for the Bacillus Coagulans Market is estimated to be 4.2%.
The cosmetics segment would garner a significant market value share by 2023.
Bacillus Coagulans Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
